US Stock MarketDetailed Quotes

ERNA Eterna Therapeutics

Watchlist
  • 0.323
  • -0.010-3.03%
Close Jan 8 16:00 ET
  • 0.322
  • -0.002-0.46%
Post 20:01 ET
16.61MMarket Cap-0.04P/E (TTM)

Eterna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7.90%-6.29M
41.66%-2.26M
38.06%-3.75M
2.71%-20.41M
14.24%-4.66M
4.74%-5.83M
3.03%-3.87M
-11.36%-6.05M
10.69%-20.98M
20.45%-5.44M
Net income from continuing operations
-375.84%-26.6M
-22.65%-5.53M
-22.73%-6.65M
11.84%-21.67M
-37.07%-6.15M
23.59%-5.59M
-32.67%-4.51M
42.23%-5.42M
79.94%-24.58M
43.55%-4.49M
Operating gains losses
113,345.00%22.65M
28.42%-136K
51.11%68K
98.07%-203K
91.61%-38K
97.69%-20K
98.26%-190K
-97.34%45K
-212.45%-10.52M
---453K
Depreciation and amortization
-12.77%451K
817.46%578K
772.58%541K
125.96%1.12M
459.30%481K
327.27%517K
-58.55%63K
-55.07%62K
8.28%497K
-30.08%86K
Other non cash items
-42.42%95K
12.01%653K
1,917.65%1.03M
467.76%1.22M
165.72%416K
685.71%165K
96.96%583K
-90.38%51K
-99.75%214K
---633K
Change In working capital
-206.35%-3.28M
5,252.94%1.75M
166.22%980K
-157.06%-2.12M
236.44%468K
-173.91%-1.07M
-101.54%-34K
-470.93%-1.48M
261.94%3.71M
63.35%-343K
-Change in receivables
105.18%41K
136.50%123K
-75.66%74K
301.15%527K
5,508.00%1.35M
-241.38%-792K
-339.01%-337K
308.22%304K
60.24%-262K
96.23%-25K
-Change in prepaid assets
289.68%491K
87.81%-73K
-0.74%807K
-197.33%-556K
-330.93%-896K
-17.11%126K
41.56%-599K
172.82%813K
78.00%-187K
49.81%388K
-Change in payables and accrued expense
-150.49%-563K
-25.60%651K
101.09%24K
-193.15%-4.65M
-2,106.33%-4.43M
-54.93%1.12M
-51.63%875K
-553.50%-2.2M
1,128.87%4.99M
176.47%221K
-Change in other current assets
--0
100.27%1K
--0
256.97%1.01M
1,346.03%3.93M
-610.53%-2.43M
-578.18%-373K
-263.64%-108K
---646K
-1,116.13%-315K
-Change in other current liabilities
-592.51%-2.76M
174.25%1.1M
122.99%123K
621.08%964K
187.91%538K
193.03%561K
-70.04%400K
-75.41%-535K
37.71%-185K
-124.18%-612K
-Change in other working capital
-239.54%-487K
---47K
-119.20%-48K
--582K
---17K
--349K
--0
--250K
----
----
Cash from discontinued investing activities
Operating cash flow
-7.88%-6.29M
41.66%-2.26M
38.06%-3.75M
2.71%-20.41M
14.24%-4.66M
4.74%-5.83M
3.03%-3.87M
-11.36%-6.05M
10.69%-20.98M
20.45%-5.44M
Investing cash flow
Cash flow from continuing investing activities
-19K
-249K
-97K
59.57%-19K
-114.73%-19K
0
0
0
99.79%-47K
187.76%129K
Net PPE purchase and sale
---19K
---249K
---97K
59.57%-19K
-114.73%-19K
--0
--0
--0
69.48%-47K
187.76%129K
Cash from discontinued investing activities
Investing cash flow
---19K
---249K
---97K
59.57%-19K
-114.73%-19K
--0
--0
--0
99.79%-47K
187.76%129K
Financing cash flow
Cash flow from continuing financing activities
-54.48%3.89M
-107.05%-22K
1.39M
-15.44%16.56M
1.46%7.7M
142,233.33%8.54M
2,500.00%312K
0
-68.21%19.58M
1,912.17%7.59M
Net issuance payments of debt
-55.40%3.89M
--0
--1.41M
825,250.00%16.5M
778,900.00%7.79M
--8.72M
--0
--0
99.79%-2K
99.76%-1K
Net common stock issuance
--0
----
----
-98.38%320K
--0
--0
----
----
-68.48%19.71M
470.64%7.71M
Cash dividends paid
--0
----
----
0.00%-16K
0.00%-8K
--0
----
----
-100.00%-16K
0.00%-8K
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
-30.00%7K
--0
Net other financing activities
--0
---14K
---20K
-116.38%-251K
31.53%-76K
----
----
----
---116K
---111K
Cash from discontinued financing activities
Financing cash flow
-54.48%3.89M
-107.05%-22K
--1.39M
-15.44%16.56M
1.46%7.7M
142,233.33%8.54M
2,500.00%312K
--0
-68.21%19.58M
1,912.17%7.59M
Net cash flow
Beginning cash position
12.63%6.68M
-2.96%9.21M
-24.91%11.67M
-8.50%15.54M
-34.77%8.65M
-69.43%5.93M
-59.61%9.49M
-8.50%15.54M
942.02%16.99M
-45.64%13.25M
Current changes in cash
-189.06%-2.42M
28.93%-2.53M
59.35%-2.46M
-168.07%-3.87M
32.23%3.02M
144.11%2.71M
13.02%-3.56M
-192.85%-6.05M
-109.40%-1.44M
130.91%2.29M
End cash Position
-50.68%4.26M
12.63%6.68M
-2.96%9.21M
-24.91%11.67M
-24.91%11.67M
-34.77%8.65M
-69.43%5.93M
-59.61%9.49M
-8.50%15.54M
-8.50%15.54M
Free cash flow
-8.20%-6.3M
35.23%-2.51M
36.39%-3.85M
3.98%-20.43M
14.22%-4.68M
5.41%-5.83M
7.37%-3.87M
-10.42%-6.05M
10.02%-21.27M
21.82%-5.46M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7.90%-6.29M 41.66%-2.26M 38.06%-3.75M 2.71%-20.41M 14.24%-4.66M 4.74%-5.83M 3.03%-3.87M -11.36%-6.05M 10.69%-20.98M 20.45%-5.44M
Net income from continuing operations -375.84%-26.6M -22.65%-5.53M -22.73%-6.65M 11.84%-21.67M -37.07%-6.15M 23.59%-5.59M -32.67%-4.51M 42.23%-5.42M 79.94%-24.58M 43.55%-4.49M
Operating gains losses 113,345.00%22.65M 28.42%-136K 51.11%68K 98.07%-203K 91.61%-38K 97.69%-20K 98.26%-190K -97.34%45K -212.45%-10.52M ---453K
Depreciation and amortization -12.77%451K 817.46%578K 772.58%541K 125.96%1.12M 459.30%481K 327.27%517K -58.55%63K -55.07%62K 8.28%497K -30.08%86K
Other non cash items -42.42%95K 12.01%653K 1,917.65%1.03M 467.76%1.22M 165.72%416K 685.71%165K 96.96%583K -90.38%51K -99.75%214K ---633K
Change In working capital -206.35%-3.28M 5,252.94%1.75M 166.22%980K -157.06%-2.12M 236.44%468K -173.91%-1.07M -101.54%-34K -470.93%-1.48M 261.94%3.71M 63.35%-343K
-Change in receivables 105.18%41K 136.50%123K -75.66%74K 301.15%527K 5,508.00%1.35M -241.38%-792K -339.01%-337K 308.22%304K 60.24%-262K 96.23%-25K
-Change in prepaid assets 289.68%491K 87.81%-73K -0.74%807K -197.33%-556K -330.93%-896K -17.11%126K 41.56%-599K 172.82%813K 78.00%-187K 49.81%388K
-Change in payables and accrued expense -150.49%-563K -25.60%651K 101.09%24K -193.15%-4.65M -2,106.33%-4.43M -54.93%1.12M -51.63%875K -553.50%-2.2M 1,128.87%4.99M 176.47%221K
-Change in other current assets --0 100.27%1K --0 256.97%1.01M 1,346.03%3.93M -610.53%-2.43M -578.18%-373K -263.64%-108K ---646K -1,116.13%-315K
-Change in other current liabilities -592.51%-2.76M 174.25%1.1M 122.99%123K 621.08%964K 187.91%538K 193.03%561K -70.04%400K -75.41%-535K 37.71%-185K -124.18%-612K
-Change in other working capital -239.54%-487K ---47K -119.20%-48K --582K ---17K --349K --0 --250K ---- ----
Cash from discontinued investing activities
Operating cash flow -7.88%-6.29M 41.66%-2.26M 38.06%-3.75M 2.71%-20.41M 14.24%-4.66M 4.74%-5.83M 3.03%-3.87M -11.36%-6.05M 10.69%-20.98M 20.45%-5.44M
Investing cash flow
Cash flow from continuing investing activities -19K -249K -97K 59.57%-19K -114.73%-19K 0 0 0 99.79%-47K 187.76%129K
Net PPE purchase and sale ---19K ---249K ---97K 59.57%-19K -114.73%-19K --0 --0 --0 69.48%-47K 187.76%129K
Cash from discontinued investing activities
Investing cash flow ---19K ---249K ---97K 59.57%-19K -114.73%-19K --0 --0 --0 99.79%-47K 187.76%129K
Financing cash flow
Cash flow from continuing financing activities -54.48%3.89M -107.05%-22K 1.39M -15.44%16.56M 1.46%7.7M 142,233.33%8.54M 2,500.00%312K 0 -68.21%19.58M 1,912.17%7.59M
Net issuance payments of debt -55.40%3.89M --0 --1.41M 825,250.00%16.5M 778,900.00%7.79M --8.72M --0 --0 99.79%-2K 99.76%-1K
Net common stock issuance --0 ---- ---- -98.38%320K --0 --0 ---- ---- -68.48%19.71M 470.64%7.71M
Cash dividends paid --0 ---- ---- 0.00%-16K 0.00%-8K --0 ---- ---- -100.00%-16K 0.00%-8K
Proceeds from stock option exercised by employees ---- ---- ---- --0 ---- ---- ---- ---- -30.00%7K --0
Net other financing activities --0 ---14K ---20K -116.38%-251K 31.53%-76K ---- ---- ---- ---116K ---111K
Cash from discontinued financing activities
Financing cash flow -54.48%3.89M -107.05%-22K --1.39M -15.44%16.56M 1.46%7.7M 142,233.33%8.54M 2,500.00%312K --0 -68.21%19.58M 1,912.17%7.59M
Net cash flow
Beginning cash position 12.63%6.68M -2.96%9.21M -24.91%11.67M -8.50%15.54M -34.77%8.65M -69.43%5.93M -59.61%9.49M -8.50%15.54M 942.02%16.99M -45.64%13.25M
Current changes in cash -189.06%-2.42M 28.93%-2.53M 59.35%-2.46M -168.07%-3.87M 32.23%3.02M 144.11%2.71M 13.02%-3.56M -192.85%-6.05M -109.40%-1.44M 130.91%2.29M
End cash Position -50.68%4.26M 12.63%6.68M -2.96%9.21M -24.91%11.67M -24.91%11.67M -34.77%8.65M -69.43%5.93M -59.61%9.49M -8.50%15.54M -8.50%15.54M
Free cash flow -8.20%-6.3M 35.23%-2.51M 36.39%-3.85M 3.98%-20.43M 14.22%-4.68M 5.41%-5.83M 7.37%-3.87M -10.42%-6.05M 10.02%-21.27M 21.82%-5.46M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion with Explanatory Notes -- -- -- -- -- --
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Symbol Mini Chart % Chg
Oracle
ORCL
+0.69%
Salesforce
CRM
+0.61%
Microsoft
MSFT
+0.52%
Cisco
CSCO
+0.46%
Broadcom
AVGO
+0.29%

Unlock the Full List